Michel Farnier, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Omega-3 Fatty Acids in Patients with ASCVD Risk: The Role of Icosapent Ethyl ...
Christopher P. Cannon, MD
Samuel Dagogo-Jack, MD, DSc
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients wit...
Ewa A. Jankowska, MD, PhD, FESC
Stefan D. Anker, MD, PhD
Beyond Anemia: Understanding the Significance and Treatment of Iron Deficiency
Robert J. Mentz, MD
Piotr Ponikowski, MD, PHD, FESC, FHFA
Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency
Sergio Fazio, MD, PhD
Practical Considerations to Manage Residual ASCVD Risk
Ileana L. Piña, MD, MPH, FAHA, FACC
Patrick Rossignol, MD, PhD
Potassium Binders in Heart Failure: Who, When, and How
Jennifer Caudle, DO
Nicole Bernard Washington, DO, MPH
Taking Care of Yourself While Taking Care of Others During COVID-19
Suneet Mittal, MD FACC FHRS
Aysha Arshad MD, FACC, FHRS, FAHA
Telemedicine During COVID-19 Outbreak
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
C. Michael Gibson, MD, MS
COVID-19 & Cardiovascular Considerations
Deepak L. Bhatt, MD, MPH, Chair
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Daniel E. Hilleman, PharmD, FCCP
Evidence and Value of Prescription Omega-3 Fatty Acids in Cardiovascular Dise...
Ravindra L. Mehta, MD
Rajit K. Basu, MD, MS, FCCM
Acute Kidney Injury: Finding a Pathway to Improved Patient Outcomes
Rod S. Passman, MD
Steven Steinbuhl, MD
Consumer Wearable Technology for AF Screening, Detection, and Management: Bol...
Andrew Epstein, MD
5 Key Takeaways on Managing Afib in the Post-CABANA Era
Jagmeet P. Singh, MD, MSc DPhil
John M. Miller, MD
Heart-to-Heart Clinical Intensive: Considerations for Rhythm Control Post CABANA
Matt Birnholz, MD
Joshua D. Lee, MD
Opioid Use Disorder: Expanding Access to Treatment
Thomas C. Wright, Jr., MD
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Pa...
